From: Second-generation antipsychotic medications and metabolic disturbance in children and adolescents
Characteristics | SGA (n = 72) | CTL (n = 79) | X2 | P |
---|---|---|---|---|
BMI ≤ 85th n (%) BMI ≥ 85th n (%) | 23 (31.51) 49 (68.06) | 70 (88.61) 9 (11.39) | 51.12 |  < 0.0001* |
WC ≤ 90th n (%) WC ≥ 90th n (%) | 44 (61.11) 28 (38.89) | 76 (96.20) 3 (3.80) | 28.43 |  < 0.0001* |
Cholesterol ≤ 90th, n (%) | 50 (69.44) | 76 (96.20) | 19.52 |  < 0.0001  < 0.0001 |
Cholesterol ≥ 90th, n (%) | 22 (30.55) | 3 (3.80) | ||
LDL ≤ 90th, n (%) LDL ≥ 90th, n (%) | 47 (65.28) 25 (34.27) | 75 (94.94) 4 (5.06) | 21.35 | |
HDL ≤ 50th, n (%) HDL ≥ 50th, n (%) | 69 (95.83) 3 (4.17) | 55 (69.52) 24 (30.38) | 17.36 |  < 0.0001 |
TG ≤ 90th, n (%) TG ≥ 90th, n (%) | 35 (52.78) 37 (47.22) | 74 (93.67) 5 (6.33) | 38.09 |  < 0.0001 |
FBS ≤ 99th, n (%) FBS ≥ 99th, n (%) | 56 (77.77) 16 (22.22) | 77 (97.46) 2 (2.53) | 13.91 | 0.0002 |
MtS < 3; n (%) MtS ≥ 3; n (%) | 30 (41.66) 42 (58.33) | 78 (98.73) 1 (1.27) | 60.23 |  < 0.0001* |